VMI
PDSB icon

VHCP Management II’s PDS Biotechnology PDSB Stock Holding History

VHCP Management II’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-48,755
Closed -$9.14M – 20
2017
Q4 		$9.14M Sell
48,755
-15,208
-24% -$3.06M 2.19% 12
2017
Q3 		$13.7M Sell
63,963
-32,716
-34% -$6.76M 3.79% 8
2017
Q2 		$19.8M Hold
96,679
– – 7.92% 4
2017
Q1 		$17.6M Hold
96,679
– – 7.21% 5
2016
Q4 		$24.2M Hold
96,679
– – 11.59% 3
2016
Q3 		$20.1M Hold
96,679
– – 10.33% 3
2016
Q2 		$19.5M Hold
96,679
– – 11.8% 2
2016
Q1 		$17.7M Hold
96,679
– – 11.64% 2
2015
Q4 		$22.2M Buy
+96,679
New +$31.2M 18.21% 1

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VHCP Management II's PDSB Position: Q1 2018 in Review

VHCP Management II sold out of PDS Biotechnology (PDSB) in Q1 2018, closing a stake of 48,755 shares — an estimated $9.14M sold.

VHCP Management II first reported a position in PDSB in Q4 2015 and held it in 9 quarters. The position peaked at $24.2M in Q4 2016. 60 funds tracked by Wall St. Rank hold PDSB as of Q1 2018.

  • VHCP Management II reported no remaining PDS Biotechnology position as of Q1 2018 after selling out during the quarter.
  • VHCP Management II sold 48,755 PDS Biotechnology shares in Q1 2018, an estimated $9.14M.
  • VHCP Management II first reported a position in PDS Biotechnology in Q4 2015 and held it in 9 quarters.
  • VHCP Management II's PDS Biotechnology position peaked at $24.2M in Q4 2016.
  • 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2018.

Based on VHCP Management II's 13F filing for Q1 2018, filed 14 May 2018.